Global Brain Monitoring Market is valued at approximately USD 6.01 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.35% during the forecast period 2023-2030. Brain monitoring devices are used for monitoring and diagnosing neurological conditions by examining the structure and function of the brain. Various devices, including electroencephalography devices, intracranial pressure monitors, and magnetoencephalography, are employed to track brain functions. These devices also aid in monitoring neural and electrical activity in the brain. Brain monitoring involves continuously observing and recording brain activity using various techniques to help diagnose disorders, guide treatments, and assess brain health during surgeries or critical care. The gathered data aids in understanding brain function and informing medical interventions. The growth of the Brain Monitoring Market is driven by the growing awareness of neurodegenerative diseases, a rise in traumatic brain injuries, the widening therapeutic applications of brain monitoring tools, and the surging use of brain monitoring in clinical trials.

Additionally, the increasing incidence of neurological disorders is directly associated with the growth of the Brain Monitoring Market across the globe. As per the research from the Alzheimer Disease International Organization, the number of individuals worldwide affected by dementia was around 55 million in 2020. This number is projected to increase to 78 million by 2030 and reach 139 million by 2050. Also, neurological diseases like autism are widespread globally, with the World Health Organization (WHO) estimating that one in 100 children worldwide has autism. This escalating prevalence of brain disorders is likely to positively impact the Brain Monitoring Market. Furthermore, strategic initiatives such as product launches, mergers, and acquisitions are anticipated to contribute to market growth. For example, NeuroWave Systems Inc. received FDA clearance for its NeuroSENSE NS-901 Monitor, designed for assessing anesthesia and sedation adequacy in clinical settings. Additionally, Brain Scientific obtained FDA clearance for the Next-Gen NeuroCap EEG Headset, an advanced electroencephalography (EEG) electrode array facilitating rapid EEGs in routine clinical and research settings. Thus, these aforementioned factors are propelling the growth of the Brain Monitoring Market over the estimated period. Moreover, the rising demand for non-invasive and minimally invasive devices, as well as the expanding healthcare sector in emerging economies present various lucrative opportunities over the forecast years. However, the unavailability of skilled professionals to handle devices and the stringent regulations for device approval are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Brain Monitoring Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the well-established healthcare infrastructure, a surge in clinical trials for brain monitoring products, and the accessibility of medical reimbursement. Furthermore, the market in the region has witnessed growth due to favorable reimbursement policies and ongoing technological advancements. Accordingly, the development of mobile EEG machines, real-time monitoring, and alert systems has played a significant role in contributing to the regional market expansion. For instance, in May 2022, Philips received FDA 510(k) clearance for its latest MR 7700 3.0T MR system, empowering radiologists to capture six distinct clinically relevant nuclei across various anatomies. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The surge in neurological diseases, growing aging population, and increase in healthcare expenditure are significantly propelling the market demand across the region.

Major market players included in this report are:
Natus Medical Incorporated
Medtronic PLC
Integra Lifesciences Corporation
General Electric Company
Nihon Kohden Corporation
Masimo Corporation
Advanced Brain Monitoring Inc.
Cadwell Industries Inc.
Koninklijke Philips NV
Nonin Medical Inc.
Recent Developments in the Market:
In December 2023, Nihon Kohden introduced the One View function of their Neuromaster G1 intraoperative neuromonitoring (IONM) system. The new technology incorporates extensive neurological data into the IONM software while smoothly integrating patient anesthetic and vital signs, including temperature, heart rate, SpO2, and more.
In February 2022, Masimo obtained FDA clearance for its SedLine brain function monitoring for pediatric patients (1-17 years old) and the corresponding SedLine Pediatric EEG Sensor. This clearance extends the application of SedLine to all patients aged one and above in the United States, utilizing advanced signal processing technology to enable bilateral brain activity monitoring through Masimo's four-lead SedLine EEG sensors.
In October 2022, Medtronic announced the introduction of the Medtronic Neurovascular Co-lab-a platform and innovation process dedicated to generating novel ideas for advancing stroke care.
Global Brain Monitoring Market Report Scope:
Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product Type, Application, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Magnetoencephalograph
Electroencephalograph
Cerebral Oximeters
Functional Magnetic Resonance Imaging (fMRI)
Intracranial Pressure Monitoring Devices
Other Product Types
By Application:
Parkinson's Disease
Traumatic Brain Injury
Epilepsy
Dementia
Sleep Disorders
Other Applications
By End User:
Hospitals
Diagnostic Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa